Spire Healthcare Group (LON:SPI) Shares Up 14.1% - What's Next?

Key Points

• Spire Healthcare Group's stock price increased by 14.1%, reaching a peak of GBX 256.50 on Saturday, with a trading volume surging by 563% compared to the average daily volume.
• Analysts are generally optimistic about Spire Healthcare, with a consensus rating of "Buy" and an average price target of GBX 294.33, despite some recent adjustments from institutions.
• The company reported an EPS of GBX 4.10 for the last quarter, with expectations of a total annual EPS of approximately 15.66 for the current year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares shot up 14.1% on Saturday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares were traded during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on SPI shares. JPMorgan Chase & Co. reduced their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Berenberg Bank reiterated a "buy" rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a research note on Thursday, July 31st. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of GBX 294.33.

Spire Healthcare Group Price Performance

The stock has a market cap of £947.58 million, a P/E ratio of 5,119.57, a PEG ratio of 1.06 and a beta of 0.96. The firm's fifty day moving average price is GBX 218.99 and its 200-day moving average price is GBX 203.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.